Table 1.
Demographics of patients with and without care gaps
| No care gap | Care gap | P | |
|---|---|---|---|
| Number of VW admissions | 17 | 35 | |
| Age | 58 (40–61) | 49 (41–55) | 0.27 |
| Male | 8 (47) | 17 (49) | 1.00 |
| Cause of end stage renal disease | 0.19 | ||
| Glomerulonephritis | 7 (41) | 5 (14) | |
| Diabetes | 3 (18) | 2 (6) | |
| Congenital disease | 2 (12) | 8 (23) | |
| Calcineurin inhibitor toxicity | 2 (12) | 8 (23) | |
| Hemolytic uremic syndrome | 1 (6) | 2 (6) | |
| Systemic lupus erythematous | 0 | 3 (9) | |
| Renal cell carcinoma | 0 | 2 (6) | |
| Hypertension | 1 (6) | 1 (3) | |
| Vasculitis | 0 | 1 (3) | |
| Undetermined | 1 (6) | 3 (9) | |
| Duration of RRT (years) | 8.8 (1.4–19.1) | 12.2 (3.6–20) | 0.35 |
| Duration of HHD (years) | 2.3 (0.6–4.8) | 3.3 (0.7–5.5) | 0.74 |
| Charlson comorbidity Index (CCI) | 4 (3–6) | 5 (4–7) | 0.22 |
| Cancer history | 6 (35) | 12 (34) | 1.00 |
| Previous transplant | 7 (41) | 17 (49) | 0.77 |
| Permanent vascular accessa | 4 (25) | 12 (35) | 0.53 |
| Admission criteria | 0.07 | ||
| Hospital discharge | 14 (82) | 30 (86) | |
| Completed medical procedure | 2 (12) | 0 | |
| Antibiotic prescription | 1 (6) | 1 (3) | |
| Completed HHD post training | 0 | 4 (11) |
Values presented as median (Interquartile range) and count (%). Percentages may exceed 100 due to rounding. VW = Virtual Ward, RRT = Renal Replacement Therapy, HHD = Home hemodialysis. aNative arteriovenous fistula or graft